ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMLX Amylyx Pharmaceuticals Inc

1.64
-0.04 (-2.38%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 952,019
Bid Price 1.45
Ask Price 2.05
News -
Day High 1.70

Low
1.62

52 Week Range

High
25.55

Day Low 1.62
Share Name Share Symbol Market Stock Type
Amylyx Pharmaceuticals Inc AMLX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.04 -2.38% 1.64 23:00:03
Open Price Low Price High Price Close Price Previous Close
1.70 1.62 1.70 1.64 1.68
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
6,586 952,019 US$ 1.65 US$ 1,566,497 - 1.62 - 25.55
Last Trade Type Quantity Price Currency
17:13:47 formt 124 US$ 1.64 USD

Amylyx Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
110.48M 67.78M - 380.79M 49.27M 0.73 2.24
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amylyx Pharmaceuticals News

Date Time Source News Article
6/07/202415:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202415:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202415:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:07Edgar (US Regulatory)Form 8-K - Current report
6/04/202408:00Business WireAmylyx Pharmaceuticals to Present at the Goldman Sachs 45th..
5/16/202418:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/09/202406:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202406:05Edgar (US Regulatory)Form 8-K - Current report
5/09/202406:00Business WireAmylyx Pharmaceuticals Reports First Quarter 2024 Financial..
5/08/202408:00Business WireAmylyx Pharmaceuticals to Present at the 2024 Bank of..
5/02/202408:00Business WireAmylyx Pharmaceuticals to Report First Quarter 2024..
4/10/202408:00Business WireAmylyx Pharmaceuticals Announces Interim Data From Ongoing..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AMLX Message Board. Create One! See More Posts on AMLX Message Board See More Message Board Posts

Historical AMLX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.711.801.621.74950,083-0.07-4.09%
1 Month1.841.901.621.741,141,236-0.20-10.87%
3 Months2.892.981.622.111,794,264-1.25-43.25%
6 Months15.2019.94881.626.142,296,725-13.56-89.21%
1 Year25.2725.551.6210.681,832,426-23.63-93.51%
3 Years21.0041.92971.6217.431,318,715-19.36-92.19%
5 Years21.0041.92971.6217.431,318,715-19.36-92.19%

Amylyx Pharmaceuticals Description

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.

Your Recent History

Delayed Upgrade Clock